FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2394867534> ?p ?o ?g. }

• W2394867534 abstract "Abstract Background The bacterial resistance of Helicobacter pylori to antimicrobial agents such as clarithromycin and metronidazole has been increasing worldwide, leading to the failure of eradication treatment. Here, we present an eradication regimen consisting of four‐times‐daily dosing (q.i.d.) of rabeprazole with potent acid inhibition. Aim To investigate the efficacy of eradication therapy with rabeprazole q.i.d. and amoxicillin or sitafloxacin in Japanese infected with a metronidazole‐resistant strain. Methods We retrospectively investigated the efficacy of eradication regimens with rabeprazole q.i.d. for 7 days in 111 Japanese pooled patients infected with a metronidazole‐resistant strain of H. pylori at Hamamatsu University School of Medicine Hospital or the Shiga University of Medical Science Hospital: 1, with sitafloxacin 100 mg twice daily (b.i.d.) (n = 82); 2, with amoxicillin 500 mg q.i.d. (n = 15); and 3, with amoxicillin q.i.d. and sitafloxacin b.i.d.‐combined regimen (n = 14). Eradication status was assessed at 8 weeks via a 13 C‐urea breath test. Results Eradication rate on intention‐to‐treat analysis was 93.7% (95% confidence interval: 87.4–97.4%, 104/111), irrespective of the high prevalence of strains resistant to clarithromycin (81.1%, 90/111) and levofloxacin (42.3%, 47/111). No significant differences in eradication rates were observed among the different treatment regimens ( p = .408), eradication history ( p = .096) and different CYP 2C19 genotypes ( p = .789). On multivariate analysis, no significant risk factor for eradication failure by therapy with potent acid inhibition was seen. Conclusion In Japanese patients infected with metronidazole‐resistant strains of H. pylori , eradication rates exceeding 90% can be achieved using appropriate dosing of antibiotic agents with strain susceptibility (amoxicillin q.i.d. and/or sitafloxacin b.i.d.) together with acid inhibition for a full 24 h and rabeprazole 10 mg q.i.d. These findings may be further evidence for dual therapy with rabeprazole q.i.d. and an antibiotic agent (amoxicillin q.i.d. or sitafloxacin b.i.d.) in Japanese patients with metronidazole‐resistant strains." @default.
• W2394867534 created "2016-06-24" @default.
• W2394867534 creator A5014733983 @default.
• W2394867534 creator A5033302261 @default.
• W2394867534 creator A5049985653 @default.
• W2394867534 creator A5058654073 @default.
• W2394867534 creator A5064263453 @default.
• W2394867534 creator A5064860145 @default.
• W2394867534 creator A5080603286 @default.
• W2394867534 creator A5088713000 @default.
• W2394867534 date "2016-05-23" @default.
• W2394867534 modified "2023-10-04" @default.
• W2394867534 title "Four-times-daily Dosing of Rabeprazole with Sitafloxacin, High-Dose Amoxicillin, or Both for Metronidazole-Resistant Infection with<i>Helicobacter pylori</i>in Japan" @default.
• W2394867534 cites W1483337133 @default.
• W2394867534 cites W1535890761 @default.
• W2394867534 cites W1801874196 @default.
• W2394867534 cites W1969054251 @default.
• W2394867534 cites W1979341204 @default.
• W2394867534 cites W1980874820 @default.
• W2394867534 cites W1981314660 @default.
• W2394867534 cites W1983848046 @default.
• W2394867534 cites W2012004433 @default.
• W2394867534 cites W2014204448 @default.
• W2394867534 cites W2016950747 @default.
• W2394867534 cites W2029339785 @default.
• W2394867534 cites W2036432661 @default.
• W2394867534 cites W2038460042 @default.
• W2394867534 cites W2050132242 @default.
• W2394867534 cites W2064354786 @default.
• W2394867534 cites W2067910657 @default.
• W2394867534 cites W2077642428 @default.
• W2394867534 cites W2077994119 @default.
• W2394867534 cites W2078860506 @default.
• W2394867534 cites W2080839245 @default.
• W2394867534 cites W2084322643 @default.
• W2394867534 cites W2084491961 @default.
• W2394867534 cites W2092087978 @default.
• W2394867534 cites W2096358993 @default.
• W2394867534 cites W2098162091 @default.
• W2394867534 cites W2111942462 @default.
• W2394867534 cites W2117044556 @default.
• W2394867534 cites W2120771508 @default.
• W2394867534 cites W2132067762 @default.
• W2394867534 cites W2133833697 @default.
• W2394867534 cites W2140383361 @default.
• W2394867534 cites W2140716502 @default.
• W2394867534 cites W2148000262 @default.
• W2394867534 cites W2150461008 @default.
• W2394867534 cites W2158819521 @default.
• W2394867534 cites W2163478143 @default.
• W2394867534 cites W2164497230 @default.
• W2394867534 cites W2263960908 @default.
• W2394867534 doi "https://doi.org/10.1111/hel.12319" @default.
• W2394867534 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27213463" @default.
• W2394867534 hasPublicationYear "2016" @default.
• W2394867534 type Work @default.
• W2394867534 sameAs 2394867534 @default.
• W2394867534 citedByCount "10" @default.
• W2394867534 countsByYear W23948675342017 @default.
• W2394867534 countsByYear W23948675342018 @default.
• W2394867534 countsByYear W23948675342020 @default.
• W2394867534 countsByYear W23948675342021 @default.
• W2394867534 countsByYear W23948675342023 @default.
• W2394867534 crossrefType "journal-article" @default.
• W2394867534 hasAuthorship W2394867534A5014733983 @default.
• W2394867534 hasAuthorship W2394867534A5033302261 @default.
• W2394867534 hasAuthorship W2394867534A5049985653 @default.
• W2394867534 hasAuthorship W2394867534A5058654073 @default.
• W2394867534 hasAuthorship W2394867534A5064263453 @default.
• W2394867534 hasAuthorship W2394867534A5064860145 @default.
• W2394867534 hasAuthorship W2394867534A5080603286 @default.
• W2394867534 hasAuthorship W2394867534A5088713000 @default.
• W2394867534 hasBestOaLocation W23948675341 @default.
• W2394867534 hasConcept C126322002 @default.
• W2394867534 hasConcept C2775981797 @default.
• W2394867534 hasConcept C2776409635 @default.
• W2394867534 hasConcept C2776962512 @default.
• W2394867534 hasConcept C2777396551 @default.
• W2394867534 hasConcept C2779116819 @default.
• W2394867534 hasConcept C2779708577 @default.
• W2394867534 hasConcept C2781276175 @default.
• W2394867534 hasConcept C2781413609 @default.
• W2394867534 hasConcept C501593827 @default.
• W2394867534 hasConcept C71924100 @default.
• W2394867534 hasConcept C86803240 @default.
• W2394867534 hasConcept C89423630 @default.
• W2394867534 hasConcept C90924648 @default.
• W2394867534 hasConceptScore W2394867534C126322002 @default.
• W2394867534 hasConceptScore W2394867534C2775981797 @default.
• W2394867534 hasConceptScore W2394867534C2776409635 @default.
• W2394867534 hasConceptScore W2394867534C2776962512 @default.
• W2394867534 hasConceptScore W2394867534C2777396551 @default.
• W2394867534 hasConceptScore W2394867534C2779116819 @default.
• W2394867534 hasConceptScore W2394867534C2779708577 @default.
• W2394867534 hasConceptScore W2394867534C2781276175 @default.
• W2394867534 hasConceptScore W2394867534C2781413609 @default.
• W2394867534 hasConceptScore W2394867534C501593827 @default.
• W2394867534 hasConceptScore W2394867534C71924100 @default.
• W2394867534 hasConceptScore W2394867534C86803240 @default.
• W2394867534 hasConceptScore W2394867534C89423630 @default.

• next